Molecular basis for different ability of low-density and high-density lipoproteins to support activity of the intrinsic Xase complex.

[1]  J. Cruickshank,et al.  Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men. , 1989, Atherosclerosis.

[2]  B. Furie,et al.  Binding of human factor VIII to phospholipid vesicles. , 1990, The Journal of biological chemistry.

[3]  R. Lawn,et al.  Distribution of factor VIII mRNA and antigen in human liver and other tissues , 1985, Nature.

[4]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[5]  M. J. Chapman.  [3] Comparative analysis of mammalian plasma lipoproteins , 1986 .

[6]  P. Fay.  Regulation of Factor VIIIa in the Intrinsic Factor Xase , 1999, Thrombosis and Haemostasis.

[7]  Joseph M. Scandura,et al.  Structural and Functional Characterization of Platelet Receptor-mediated Factor VIII Binding* , 2000, The Journal of Biological Chemistry.

[8]  G. E. Gilbert,et al.  Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII Inhibition* , 1996, The Journal of Biological Chemistry.

[9]  D. Josić,et al.  Comparison of the properties of phospholipid surfaces formed on HPA and L1 biosensor chips for the binding of the coagulation factor VIII. , 2001, Journal of chromatography. A.

[10]  M. Setaka,et al.  Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography. , 2000, Journal of lipid research.

[11]  M. Blombäck,et al.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.

[12]  G. Assmann,et al.  Coagulation factor VII and the risk of coronary heart disease in healthy men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[13]  K. Mann,et al.  Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[14]  G. Lowe,et al.  Effects of lipids and lipoproteins on thrombosis and rheology. , 1998, Atherosclerosis.

[15]  R. D. Carlson,et al.  A simple method for the preparation of homogeneous phospholipid vesicles. , 1977, Biochemistry.

[16]  W. Koenig,et al.  Association Between Rheology and Components of Lipoproteins in Human Blood: Results From the MONICA Project , 1992, Circulation.

[17]  L. Tavazzi,et al.  The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[18]  G. E. Gilbert,et al.  Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). , 1992, The Journal of biological chemistry.

[19]  B. Furie,et al.  Membrane binding kinetics of factor VIII indicate a complex binding process. , 1993, The Journal of biological chemistry.

[20]  W. Lawson,et al.  Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  G. E. Gilbert,et al.  Phosphatidylethanolamine Induces High Affinity Binding Sites for Factor VIII on Membranes Containing Phosphatidyl-L-serine (*) , 1995, The Journal of Biological Chemistry.

[22]  E. Tremoli,et al.  Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[23]  José A Fernández,et al.  High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. , 1999, The Journal of clinical investigation.

[24]  G. E. Gilbert,et al.  Activation of the Factor VIIIa-Factor IXa Enzyme Complex of Blood Coagulation by Membranes Containing Phosphatidyl-L-serine (*) , 1996, The Journal of Biological Chemistry.

[25]  M. Shima,et al.  Role of activation of the coagulation factor VIII in interaction with vWf, phospholipid, and functioning within the factor Xase complex. , 1999, Trends in cardiovascular medicine.

[26]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[27]  E. Saenko,et al.  The Acidic Region of the Factor VIII Light Chain and the C2 Domain Together Form the High Affinity Binding Site for von Willebrand Factor* , 1997, The Journal of Biological Chemistry.

[28]  K. Rye,et al.  The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study. , 2000, Biochemistry.

[29]  E. Saenko,et al.  A Mechanism for Inhibition of Factor VIII Binding to Phospholipid by von Willebrand Factor (*) , 1995, The Journal of Biological Chemistry.

[30]  J. Abel,et al.  Lipoproteins and coagulation , 1997, Perfusion.

[31]  H. Hemker,et al.  The role of phospholipid and factor VIIIa in the activation of bovine factor X. , 1981, The Journal of biological chemistry.

[32]  E. Saenko,et al.  Activation of Factor VIII by Thrombin Increases Its Affinity for Binding to Synthetic Phospholipid Membranes and Activated Platelets* , 1998, The Journal of Biological Chemistry.

[33]  B. Keyt,et al.  Structure of human factor VIII , 1984, Nature.

[34]  D. Gabriel,et al.  The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding. , 1997, Biochemistry.

[35]  M. Mancini,et al.  Increased Fibrinogen Binding to Platelets from Patients with Familial Hypercholesterolemia , 1986, Arteriosclerosis.

[36]  A. Giles,et al.  The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. , 1991, The Journal of biological chemistry.

[37]  P. Lenting,et al.  Electron Crystallography of Human Blood Coagulation Factor VIII Bound to Phospholipid Monolayers* , 1999, The Journal of Biological Chemistry.

[38]  G. Dagenais,et al.  Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.

[39]  P. Lollar,et al.  Factor VIII and factor VIIIa. , 1993, Methods in enzymology.

[40]  R. Muche,et al.  Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) , 1994, European journal of clinical investigation.

[41]  V. Kakkar,et al.  Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidemia. , 1981, The American journal of medicine.